Compare ARCB & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARCB | PGEN |
|---|---|---|
| Founded | 1923 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.6B |
| IPO Year | 1994 | 2013 |
| Metric | ARCB | PGEN |
|---|---|---|
| Price | $105.09 | $4.31 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 5 |
| Target Price | ★ $97.92 | $7.67 |
| AVG Volume (30 Days) | 384.6K | ★ 3.7M |
| Earning Date | 05-01-2026 | 01-01-0001 |
| Dividend Yield | ★ 0.46% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.96 | N/A |
| Revenue | ★ $1,657,864,000.00 | $230,981,000.00 |
| Revenue This Year | $5.58 | $342.78 |
| Revenue Next Year | $6.47 | $478.46 |
| P/E Ratio | $35.50 | ★ N/A |
| Revenue Growth | ★ 12.56 | N/A |
| 52 Week Low | $55.19 | $1.11 |
| 52 Week High | $112.92 | $5.47 |
| Indicator | ARCB | PGEN |
|---|---|---|
| Relative Strength Index (RSI) | 61.80 | 47.84 |
| Support Level | $102.26 | $4.34 |
| Resistance Level | $107.47 | $5.47 |
| Average True Range (ATR) | 5.31 | 0.41 |
| MACD | -0.65 | -0.02 |
| Stochastic Oscillator | 67.80 | 27.51 |
ArcBest Corp is an integrated logistics company that leverages technology and a full suite of shipping and logistics solutions to meet customers' supply chain needs. The company has two reportable operating segments: Asset-Based, which generates maximum revenue, and Asset-Light. The Asset-Based segment's operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed less-than-truckload services. The Asset-Light segment represents the company's offerings in ground expedite, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.